The order is carried out in connection with the planned application for funding of the project entitled:
– “RESEARCH AND DEVELOPMENT OF A SMALL MOLECULE INHIBITOR OF CHITOTRIOSIDASE 1 (CHIT1) AS A NEW, EFFECTIVE THERAPY FOR NONALCOHOLIC STEATOHEPATITIS (NASH).”
As part of the competition 3/1.1.1/2020 – Fast track for Mazovia announced by The National Center of Research and Development as part of the Submeasure 1.1.1 of the Smart Growth Operational Programme 2014-2020, co-financed by the European Regional Development Fund and because of the competitiveness principle.
We hereby look for Contractor ready to perform the service:
In vivo study on therapeutic efficacy of two chitinase inhibitors and reference compound in diet-induced mouse model of non-alcoholic steatohepatitis (NASH), performed using animals with confirmed disease (biopsy and histopathological assessment).